GlassScriptPhysician profile
Paul C Nehra
NPI 1538169297
$2,945.04
in general payments reported to CMS, 2019-2025
33 companies · $308 in 2025
The $308 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $111 · 2021: $380 · 2022: $915 · 2023: $329 · 2024: $271 · 2025: $308.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $317.99 | 2022 | |
| Merz North America, INC. | $253.66 | 2019-2022 | |
| Myovant Sciences INC. | $210.05 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $167.97 | 2023-2025 | Myfembree, Gemtesa |
| Amgen INC. | $162.44 | 2019-2025 | Prolia, Evenity |
| Coopersurgical, INC. | $148.83 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $143.63 | 2021-2024 | Coolseal Generator, Myosure Tissue Removal Device |
| Therapeuticsmd, INC. | $140.63 | 2019-2021 | |
| Covidien LP | $137.22 | 2019-2020 | |
| Axonics, INC. | $131.28 | 2022-2024 | Bulkamid, Axonics |
| Medtronic, INC. | $129.31 | 2021-2023 | Truclear |
| Channel Medsystems, INC. | $116.74 | 2025 | |
| Organon LLC | $94.49 | 2021-2025 | Nexplanon |
| Abbvie INC. | $93.56 | 2020-2024 | |
| Astellas Pharma US INC | $89.51 | 2021-2024 | Veozah, Myrbetriq |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $86.76 | 2019 | |
| Caldera Medical, INC | $76.91 | 2022 | |
| Evofem Biosciences, INC. | $56.17 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $46.73 | 2022 | |
| Minerva Surgical, INC | $45.77 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $44.25 | 2020-2024 | Gardasil 9, Gardasil |
| Agile Therapeutics, INC. | $29.45 | 2021-2022 | |
| Daiichi Sankyo INC. | $29.25 | 2023-2025 | Injectafer |
| Pfizer INC. | $27.94 | 2021 | |
| Allergan, INC. | $24.42 | 2019 | |
| Baxter Healthcare | $22.52 | 2025 | Seprafilm |
| Dexcom, INC. | $21.42 | 2025 | Dexcom G6 Transmitter |
| Exact Sciences Corporation | $20.40 | 2023 | Cologuard Collection Kit |
| Millicent US INC | $18.09 | 2024 | Femring, Intrarosa |
| Bayer Healthcare Pharmaceuticals INC. | $16.46 | 2024 | |
| Seqirus USA INC | $14.32 | 2025 | Flucelvax, Fluad |
| Avion Pharmaceuticals | $13.83 | 2021 | |
| Glaxosmithkline, LLC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Nehra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.